Trial Outcomes & Findings for Tear Film Evaluation of Dailies® AquaComfort Plus® Multifocal and Toric (NCT NCT02289742)
NCT ID: NCT02289742
Last Updated: 2016-07-26
Results Overview
A video was made to capture a visual demonstration of tear film characteristics in between blinks. The investigator graded contact lens surface wettability using a scale from 0 (fully wettable) to 3 (clearly visible distortions) at 5, 10, 15, 20 and 25 seconds post-blink by region (central, superior, nasal, inferior, and temporal). Three independent measurements (3 blinks) were carried out. An average was taken over the 3 measurements, 5 regions, and 5 time points. One eye contributed to the analysis.
COMPLETED
NA
48 participants
Hour 12, each product
2016-07-26
Participant Flow
Subjects were recruited from 1 study center located in Germany.
Of the 48 enrolled subjects, 3 were discontinued as screen failures prior to randomization. This reporting group includes all randomized subjects (45).
Participant milestones
| Measure |
Presbyopes MF/Sphere
Nelfilcon A multifocal contact lenses in Period 1, followed by nelfilcon A sphere contact lenses in Periods 2 and 3. Each product worn bilaterally (in both eyes) for 12 hours.
|
Presbyopes Sphere/MF
Nelfilcon A sphere contact lenses in Periods 1 and 3, with nelfilcon A multifocal contact lenses in Period 2. Each product worn bilaterally (in both eyes) for 12 hours.
|
Astigmats Toric/Sphere
Nelfilcon A toric contact lenses in Period 1, followed by nelfilcon A sphere contact lenses in Periods 2 and 3. Each product worn bilaterally (in both eyes) for 12 hours.
|
Astigmats Sphere/Toric
Nelfilcon A sphere contact lenses in Periods 1 and 3, with nelfilcon A toric contact lenses in Period 2. Each product worn bilaterally (in both eyes) for 12 hours.
|
|---|---|---|---|---|
|
First Wear Period
STARTED
|
11
|
12
|
12
|
10
|
|
First Wear Period
Treated
|
11
|
11
|
12
|
9
|
|
First Wear Period
COMPLETED
|
11
|
11
|
11
|
9
|
|
First Wear Period
NOT COMPLETED
|
0
|
1
|
1
|
1
|
|
Second Wear Period
STARTED
|
11
|
11
|
11
|
9
|
|
Second Wear Period
COMPLETED
|
11
|
11
|
11
|
9
|
|
Second Wear Period
NOT COMPLETED
|
0
|
0
|
0
|
0
|
|
Third Wear Period
STARTED
|
11
|
11
|
11
|
9
|
|
Third Wear Period
COMPLETED
|
11
|
10
|
11
|
8
|
|
Third Wear Period
NOT COMPLETED
|
0
|
1
|
0
|
1
|
Reasons for withdrawal
| Measure |
Presbyopes MF/Sphere
Nelfilcon A multifocal contact lenses in Period 1, followed by nelfilcon A sphere contact lenses in Periods 2 and 3. Each product worn bilaterally (in both eyes) for 12 hours.
|
Presbyopes Sphere/MF
Nelfilcon A sphere contact lenses in Periods 1 and 3, with nelfilcon A multifocal contact lenses in Period 2. Each product worn bilaterally (in both eyes) for 12 hours.
|
Astigmats Toric/Sphere
Nelfilcon A toric contact lenses in Period 1, followed by nelfilcon A sphere contact lenses in Periods 2 and 3. Each product worn bilaterally (in both eyes) for 12 hours.
|
Astigmats Sphere/Toric
Nelfilcon A sphere contact lenses in Periods 1 and 3, with nelfilcon A toric contact lenses in Period 2. Each product worn bilaterally (in both eyes) for 12 hours.
|
|---|---|---|---|---|
|
First Wear Period
Adverse event prior to treatment
|
0
|
1
|
0
|
0
|
|
First Wear Period
Adverse Event
|
0
|
0
|
1
|
0
|
|
First Wear Period
Other prior to treatment
|
0
|
0
|
0
|
1
|
|
Third Wear Period
Adverse Event
|
0
|
1
|
0
|
0
|
|
Third Wear Period
Reason not given
|
0
|
0
|
0
|
1
|
Baseline Characteristics
Tear Film Evaluation of Dailies® AquaComfort Plus® Multifocal and Toric
Baseline characteristics by cohort
| Measure |
Presbyopes
n=22 Participants
Nelfilcon A contact lenses (multifocal and sphere) worn as randomized in a crossover design during Periods 1 and 2, with nelfilcon A sphere contact lenses in Period 3. Each product worn bilaterally (in both eyes) for 12 hours.
|
Astigmats
n=21 Participants
Nelfilcon A contact lenses (toric and sphere) worn as randomized in a crossover design during Periods 1 and 2, with nelfilcon A sphere contact lenses in Period 3. Each product worn bilaterally (in both eyes) for 12 hours.
|
Total
n=43 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
51.7 years
STANDARD_DEVIATION 8.1 • n=93 Participants
|
25.8 years
STANDARD_DEVIATION 4.5 • n=4 Participants
|
39.0 years
STANDARD_DEVIATION 14.6 • n=27 Participants
|
|
Sex: Female, Male
Female
|
16 Participants
n=93 Participants
|
16 Participants
n=4 Participants
|
32 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=93 Participants
|
5 Participants
n=4 Participants
|
11 Participants
n=27 Participants
|
|
Region of Enrollment
Germany
|
22 participants
n=93 Participants
|
21 participants
n=4 Participants
|
43 participants
n=27 Participants
|
PRIMARY outcome
Timeframe: Hour 12, each productPopulation: This analysis population includes all randomized and exposed subjects with data at visit.
A video was made to capture a visual demonstration of tear film characteristics in between blinks. The investigator graded contact lens surface wettability using a scale from 0 (fully wettable) to 3 (clearly visible distortions) at 5, 10, 15, 20 and 25 seconds post-blink by region (central, superior, nasal, inferior, and temporal). Three independent measurements (3 blinks) were carried out. An average was taken over the 3 measurements, 5 regions, and 5 time points. One eye contributed to the analysis.
Outcome measures
| Measure |
Presbyopes / Multifocal
n=22 Participants
Nelfilcon A multifocal contact lenses worn bilaterally (in both eyes) for 12 hours during Period 1 or 2
|
Presbyopes / Sphere
n=22 Participants
Nelfilcon A spherical contact lenses worn balaterally (in both eyes) for 12 hours during Period 1 or Period 2 (in a crossover design) and in Period 3
|
Astigmats / Toric
n=21 Participants
Nelfilcon A toric contact lenses worn bilaterally (in both eyes) for 12 hours during Period 1 or Period 2 (in a crossover design)
|
Astigmats / Sphere
n=20 Participants
Nelfilcon A spherical contact lenses worn bilaterally (in both eyes) for 12 hours during Period 1 or Period 2 (in a crossover design) and in Period 3
|
|---|---|---|---|---|
|
Percentage of Subjects With Wettability Grade of 2 or 3 After 12 Hours of Wear
|
55.8 percentage of subjects
|
47.2 percentage of subjects
|
46.5 percentage of subjects
|
49.5 percentage of subjects
|
SECONDARY outcome
Timeframe: Hour 8, each productPopulation: This analysis population includes all randomized and exposed subjects with data at visit.
A video was made to capture a visual demonstration of tear film characteristics in between blinks. The investigator graded contact lens surface wettability using a scale from 0 (fully wettable) to 3 (clearly visible distortions) at 5, 10, 15, 20 and 25 seconds post-blink by region (central, superior, nasal, inferior, and temporal). Three independent measurements (3 blinks) were carried out. An average was taken over the 3 measurements, 5 regions, and 5 time points. One eye contributed to the analysis.
Outcome measures
| Measure |
Presbyopes / Multifocal
n=22 Participants
Nelfilcon A multifocal contact lenses worn bilaterally (in both eyes) for 12 hours during Period 1 or 2
|
Presbyopes / Sphere
n=22 Participants
Nelfilcon A spherical contact lenses worn balaterally (in both eyes) for 12 hours during Period 1 or Period 2 (in a crossover design) and in Period 3
|
Astigmats / Toric
n=21 Participants
Nelfilcon A toric contact lenses worn bilaterally (in both eyes) for 12 hours during Period 1 or Period 2 (in a crossover design)
|
Astigmats / Sphere
n=20 Participants
Nelfilcon A spherical contact lenses worn bilaterally (in both eyes) for 12 hours during Period 1 or Period 2 (in a crossover design) and in Period 3
|
|---|---|---|---|---|
|
Percentage of Subjects With Wettability Grade of 2 or 3 After 8 Hours of Wear
|
60.8 percentage of subjects
|
46.3 percentage of subjects
|
34.3 percentage of subjects
|
33.3 percentage of subjects
|
Adverse Events
Pre-treatment
Presbyopes / Multifocal
Presbyopes / Sphere First Exposure
Presbyopes / Sphere Second Exposure
Astigmats / Toric
Astigmats / Sphere First Exposure
Astigmats / Sphere Second Exposure
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Global Medical Affairs, Brand Lead - Vision Care
Alcon Research, Ltd.
Results disclosure agreements
- Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
- Publication restrictions are in place
Restriction type: OTHER